LeeMHilliardMD
Pediatric Hematology & Oncology • Birmingham, ALProfessor, Pediatrics, University of Alabama School of Medicine
Dr. Hilliard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 7th Ave S
Lowder 512
Birmingham, AL 35233Phone+1 205-638-9285Fax+1 205-975-1941
Education & Training
University of Alabama Medical CenterFellowship, Pediatric Hematology/Oncology, 1993 - 1996
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 1990 - 1993
University of Mississippi School of MedicineClass of 1990
Certifications & Licensure
AL State Medical License 1993 - 2024- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Dose-Finding Study of SC411 in Children With Sickle Cell Disease Start of enrollment: 2017 Mar 02
Publications & Presentations
PubMed
- 35 citationsComplete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinomaAlexandra Walsh, David R. Kelly, Yoginder N. Vaid, Lee Hilliard, Gregory K. Friedman
Pediatric Blood & Cancer. 2010-12-01 - 29 citationsDouble-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial).Ahmed A. Daak, Carlton Dampier, Beng Fuh, Julie Kanter, Ofelia A. Alvarez
Blood Advances. 2018-08-14 - 297 citationsHydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia - TCD with Transfusions Changi...Russell E. Ware, Barry R. Davis, William H. Schultz, R. Clark Brown, Banu Aygun
Lancet. 2016-02-13
Journal Articles
- The Phenotypic Spectrum of Germline YARS2 Variants: From Isolated Sideroblastic Anemia to Mitochondrial Myopathy, Lactic Acidosis and Sideroblastic Anemia 2Matthew M Heeney, Gregory A Hale, David P Steensma, Mark D Fleming, Colin A Sieff, Lee M Hilliard, Sylvia S Bottomley, Janet L Kwiatkowski, Haematologica
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
